DRIZALMA SPRINKLE- duloxetine capsule, delayed release 
SUN PHARMACEUTICAL INDUSTRIES, INC.

----------

Medication Guide

DRIZALMA SPRINKLE (dri zal' mah)

(duloxetine delayed-release capsules)

What is the most important information I should know about DRIZALMA SPRINKLE?

DRIZALMA SPRINKLE may cause serious side effects, including:

Increased risk of suicidal thoughts or actions. DRIZALMA SPRINKLE and other antidepressant medicines may increase suicidal thoughts and actions in some people 24 years of age and younger, especially within the first few months of treatment or when the dose is changed.
Depression and other serious mental illnesses are the most important causes of suicidal thoughts or actions.
 
How can I watch for and try to prevent suicidal thoughts and actions?
o
Pay close attention to any changes in mood, behavior, actions, thoughts, or feelings, especially sudden changes. This is very important when an antidepressant medicine is started or when the dose is changed.
o
Call your healthcare provider right away to report new or sudden changes in mood, behavior, thoughts, or feelings.
o
Keep all follow-up visits with your healthcare provider as scheduled. Call your healthcare provider between visits as needed, especially if you have concerns about symptoms.
 
Call your healthcare provider or get emergency help right away if you or your family member have any of the following symptoms, especially if they are new, worse, or worry you:
attempts to commit suicide
acting on dangerous impulses
acting aggressive, being angry, or violent
thoughts about suicide or dying
new or worse depression
new or worse anxiety
panic attacks
feeling very agitated or restless
new or worse irritability
trouble sleeping
an extreme increase in activity or talking (mania)
other unusual changes in behavior or mood

What is DRIZALMA SPRINKLE?

DRIZALMA SPRINKLE is prescription medicine used to treat:

A certain type of depression called Major Depressive Disorder (MDD) in adults
Generalized Anxiety Disorder (GAD) in adults and children 7 years of age and older
Diabetic Peripheral Neuropathic Pain (DPNP) in adults
Fibromyalgia (FM) in adults
Chronic Musculoskeletal Pain in adults
 
It is not known if DRIZALMA SPRINKLE is safe and effective for use to treat GAD in children less than 7 years of age.

It is not known if DRIZALMA SPRINKLE is safe and effective for use to treat MDD, DPNP, and Chronic Musculoskeletal Pain in children.

Do not take DRIZALMA SPRINKLE if you:

take a Monoamine Oxidase Inhibitor (MAOI)
have stopped taking an MAOI in the last 14 days
are being treated with the antibiotic linezolid or intravenous methylene blue

Ask your healthcare provider or pharmacist if you are not sure if you take an MAOI, including the antibiotic linezolid or intravenous methylene blue.

Do not start taking an MAOI for a least 5 days after you stop treatment with DRIZALMA SPRINKLE.

Before taking DRIZALMA SPRINKLE, tell your healthcare provider about all your medical conditions, including if you:

have or have a family history of suicide, bipolar disorder, depression, mania or hypomania
have liver or kidney problems
drink alcohol
have or had had bleeding problems
have glaucoma (high pressure in the eye)
have or have had seizures (convulsions)
have high or low blood pressure
have diabetes or high blood sugar
have or have had heart problems or stroke
have low sodium levels in your blood
have problems urinating (hesitation) or emptying your bladder (urinary retention)
are pregnant or plan to become pregnant. DRIZALMA SPRINKLE may harm your unborn baby. Talk to your healthcare provider about the risks to you and your unborn baby if you take DRIZALMA SPRINKLE during pregnancy.
Tell your healthcare provider right away if you become pregnant or think you are pregnant during treatment with DRIZALMA SPRINKLE.
If you become pregnant during treatment with DRIZALMA SPRINKLE, talk to your healthcare provider about registering with the National Pregnancy Registry for Antidepressants. You can register by calling 1-844-405-6185 or by visiting online at https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/antidepressants/
are breastfeeding or plan to breastfeed. DRIZALMA SPRINKLE passes into your breast milk and may harm your baby. Talk to your healthcare provider about the best way to feed your baby during treatment with DRIZALMA SPRINKLE.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

DRIZALMA SPRINKLE and other medicines may affect each other causing possible serious side effects. DRIZALMA SPRINKLE may affect the way other medicines work and other medicines may affect the way DRIZALMA SPRINKLE works.

Especially tell your healthcare provider if you take:

medicines to treat migraine headaches known as triptans
tricyclic antidepressants
fentanyl
lithium
tramadol
tryptophan
buspirone
amphetamines
St. John’s Wort
other medicines containing desvenlafaxine or venlafaxine
medicines that can affect blood clotting such as aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), warfarin

Ask your healthcare provider if you are not sure if you are taking any of these medicines. Your healthcare provider can tell you if it is safe to take DRIZALMA SPRINKLE with your other medicines.

Do not start or stop any other medicines during treatment with TREATMENT without talking to your healthcare provider first. Stopping DRIZALMA SPRINKLE suddenly may cause you to have serious side effects. See, “What are the possible side effects of DRIZALMA SPRINKLE?

Know the medicines you take. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.

How should I take DRIZALMA SPRINKLE?

Take DRIZALMA SPRINKLE exactly as your healthcare provider tells you to take it. Do not change your dose or stop taking DRIZALMA SPRINKLE without talking to your healthcare provider.
Your healthcare provider may need to change the dose of DRIZALMA SPRINKLE until it is the right dose for you.
Take DRIZALMA SPRINKLE with or without food.
Swallow DRIZALMA SPRINKLE whole. Do not chew or crush DRIZALMA SPRINKLE.
If you have trouble swallowing DRIZALMA SPRINKLE whole, you can open the capsule and take the contents with applesauce. See the Instructions for Use at the end of this Medication Guide for instructions on how to take DRIZALMA SPRINKLE with applesauce.
See the Instructions for Use at the end of this Medication Guide for instructions on how to mix and give DRIZALMA SPRINKLE through a nasogastric (NG) tube.
If you miss a dose of DRIZALMA SPRINKLE, take the missed dose as soon as you remember. If it is almost time for the next dose, skip the missed dose and take your next dose at the regular time. Do not take 2 doses of DRIZALMA SPRINKLE at the same time.

If you take too much DRIZALMA SPRINKLE, call your healthcare provider or poison control center at 1800-222-1222 right away, or go to the nearest hospital emergency room.

What are the possible side effects of DRIZALMA SPRINKLE?

DRIZALMA SPRINKLE may cause serious side effects, including:

See, “What is the most important information I should know about DRIZALMA SPRINKLE?”
Liver problems. DRIZALMA SPRINKLE may cause severe liver problems that may cause death. Tell your healthcare provider right away if you develop any of the following symptoms of severe liver problems:
Decreased in blood pressure (orthostatic hypotension). You may feel lightheaded or faint when you rise too quickly from a sitting or lying position, especially when you start or restart treatment or when the dose is changed.
Falls and fainting. DRIZALMA SPRINKLE may cause you to feel sleepy or dizzy, may cause a decrease in your blood pressure when you rise to quickly from a sitting or lying position, and can slow your thinking and motor skills which may lead to falls that have caused fractures or other serious injuries.
Serotonin syndrome. A potentially life-threatening problem called serotonin syndrome can happen when you take DRIZALMA SPRINKLE with certain other medicines. See, “Who should not take DRIZALMA SPRINKLE?” Call your healthcare provider or go to the nearest hospital emergency room right away if you have any of the following signs and symptoms of serotonin syndrome:
Abnormal bleeding. Taking DRIZALMA SPRINKLE with aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), or blood thinners may add to this risk. Tell your healthcare provider right away about any unusual bleeding or bruising.
Severe skin reactions. DRIZALMA SPRINKLE may cause serious skin reactions that may need to be treated in a hospital and may be life-threating. Stop taking DRIZALMA SPRINKLE and call your healthcare provider or get emergency help right away if you develop skin blisters, peeling rash, sores in the mouth, hives or any other allergic reactions during treatment with DRIZALMA SPRINKLE.
Discontinuation syndrome. Suddenly stopping DRIZALMA SPRINKLE when you take higher doses may cause you to have serious side effects. Your healthcare provider may want to decrease your dose slowly. Symptoms may include:
Manic episodes. Manic episodes may happen in people with bipolar disorder who take DRIZALMA SPRINKLE. Symptoms may include:
Eye problems (angle-closure glaucoma). DRIZALMA SPRINKLE may cause a type of eye problem called angle-closure glaucoma in people with certain other eye conditions. You may want to undergo an eye examination to see if you are at risk and receive preventative treatment if you are. Call your healthcare provider if you have eye pain, changes in your vision, or swelling or redness in or around the eye. Seizures (convulsions).
Increases in blood pressure. Your healthcare provider should check your blood pressure regularly during treatment with DRIZALMA SPRINKLE. If you have high blood pressure, it should be controlled before you start treatment with DRIZALMA SPRINKLE.
Low sodium levels in your blood (hyponatremia). Low sodium levels can happen during treatment with DRIZALMA SPRINKLE. Low sodium levels in your blood may be serious and may cause death. Elderly people may be at greater risk for this. Signs and Symptoms of low sodium levels in your blood may include:
o
headache
o
difficulty concentrating
o
memory changes
o
confusion
o
weakness and unsteadiness on your feet which can lead to falls
 
In severe or more sudden cases, signs and symptoms include:
o
hallucinations (seeing or hearing things that are not real)
o
fainting
o
seizures
o
coma
o
respiratory arrest
o
death
Problems with urination. DRIZALMA SPRINKLE may cause you to have problems with urination including decreased urine flow and being unable to pass any urine. Tell your healthcare provider if you develop any problems with urine flow during treatment with DRIZALMA SPRINKLE.
Sexual problems (dysfunction). Taking serotonin and norepinephrine reuptake inhibitors (SNRIs), including DRIZALMA SPRINKLE, may cause sexual problems.
 
Symptoms in males may include:
o
Delayed ejaculation or inability to have an ejaculation
o
Decreased sex drive
o
Problems getting or keeping an erection
 
Symptoms in females may include:
o
Decreased sex drive
o
Delayed orgasm or inability to have an orgasm
 
Talk to your healthcare provider if you develop any changes in your sexual function or if you have any questions or concerns about sexual problems during treatment with DRIZALMA SPRINKLE. There may be treatments your healthcare provider can suggest.

Your healthcare provider may tell you to stop taking DRIZALMA SPRINKLE if you develop serious side effects during treatment with DRIZALMA SPRINKLE.

The most common side effects of DRIZALMA SPRINKLE in adults include:

The most common side effects of DRIZALMA SPRINKLE in children include:

Height and weight changes in children and adolescents may happen during treatment with DRIZALMA SPRINKLE. Your healthcare provider should check your child’s or adolescent’s height and weight during treatment with DRIZALMA SPRINKLE.

These are not all the possible side effects of DRIZALMA SPRINKLE.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store DRIZALMA SPRINKLE?

Store DRIZALMA SPRINKLE at room temperature between 68°F to 77°F (20°C to 25°C).
Store DRIZALMA SPRINKLE in a tightly closed container.
 
Keep DRIZALMA SPRINKLE and all medicines out of the reach of children.

General information about the safe and effective use of DRIZALMA SPRINKLE.

 
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use DRIZALMA SPRINKLE for a condition for which it was not prescribed. Do not give DRIZALMA SPRINKLE to other people, even if they have the same symptoms that you have. It may harm them. You may ask your healthcare provider or pharmacist for information about DRIZALMA SPRINKLE that is written for healthcare professionals.

What are the ingredients in DRIZALMA SPRINKLE?

Active ingredient: duloxetine hydrochloride

Inactive ingredients: hypromellose, hypromellose phthalate, polyethylene glycol, starch, sucrose, sugar spheres, talc, titanium dioxide, and triethyl citrate.

 
The capsule shell ingredients for 20 mg strength are D&C Yellow 10, FD &C Blue 1, FD &C Red 40, gelatin, sodium lauryl sulfate and titanium dioxide. The capsule shell ingredients for 30 mg strength are FD &C Blue 1, FD &C Red 40 and FD &C Red 3 (present in cap), gelatin, sodium lauryl sulfate and titanium dioxide. The capsule shell ingredients for 40 mg strength are gelatin, sodium lauryl sulfate and titanium dioxide. The capsule shell ingredients for 60 mg strength are D&C Yellow 10 (present in body), FD &C Blue 1, FD &C Red 40, FD &C Red 3 (present in cap), gelatin, sodium lauryl sulfate and titanium dioxide.
 
The imprinting ink for 20 mg, 30 mg, 40 mg, and 60 mg strength capsules was made of ammonia solution, black iron oxide, butyl alcohol, dehydrated alcohol, isopropyl alcohol, potassium hydroxide, propylene glycol and shellac.
 
Manufactured by:
 
Sun Pharmaceutical Industries Limited,
 
Mohali, INDIA
 
Distributed by:
 
Sun Pharmaceutical Industries, Inc.
 
Cranbury, NJ 08512
 
FDA-05
 
For more information call Sun Pharmaceutical Industries, Inc. at 1-800-818-4555.

This Medication Guide has been approved by the U.S. Food and Drug Administration. Revised: July/2021

Revised: 7/2021
SUN PHARMACEUTICAL INDUSTRIES, INC.